Jeonjinbio Co. Ltd (110020) — Financial Flexibility Index
Jeonjinbio Co. Ltd (110020) has a Financial Flexibility Index of 0.25x as of September 2025. Free cash flow of ₩323.26 Million (operating CF ₩313.21 Million minus capex ₩10.04 Million) represents 0% of total liabilities (₩1.27 Billion). Check Jeonjinbio Co. Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jeonjinbio Co. Ltd Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Jeonjinbio Co. Ltd across 10 annual periods. For the full cash flow conversion analysis, see Jeonjinbio Co. Ltd operating cash flow efficiency.
Annual Financial Flexibility Index for Jeonjinbio Co. Ltd (2015–2024)
Year-by-year free cash flow to debt coverage for Jeonjinbio Co. Ltd. Explore 110020 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.85x | ₩3.40 Billion | ₩3.01 Billion | ₩1.19 Billion | ▲ +8728.1% |
| 2023 | 0.03x | ₩371.04 Million | ₩-300.60 Million | ₩11.48 Billion | ▲ +117.1% |
| 2022 | -0.19x | ₩-1.58 Billion | ₩-3.71 Billion | ₩8.36 Billion | ▼ -487.3% |
| 2021 | -0.03x | ₩-451.59 Million | ₩-2.38 Billion | ₩14.02 Billion | ▼ -106.8% |
| 2020 | 0.47x | ₩3.49 Billion | ₩-2.31 Billion | ₩7.41 Billion | ▲ +376.3% |
| 2019 | -0.17x | ₩-598.32 Million | ₩-1.30 Billion | ₩3.51 Billion | ▲ +74.4% |
| 2018 | -0.67x | ₩-2.13 Billion | ₩-2.16 Billion | ₩3.21 Billion | ▼ -519.7% |
| 2017 | -0.11x | ₩-410.76 Million | ₩-413.19 Million | ₩3.83 Billion | ▼ -1050.2% |
| 2016 | -0.01x | ₩-33.11 Million | ₩-181.90 Million | ₩3.55 Billion | ▲ +96.0% |
| 2015 | -0.23x | ₩-1.84 Billion | ₩-1.95 Billion | ₩7.95 Billion | — |